Skip to main content
Clinical
Back
|
Clinical
Acute Coronary Syndromes
Cardiac Surgery
Covid-19
Heart Failure
Heart Health
Heart Rhythm
Hypertension
Interventional Cardiology
Mitral Valve
Pharmaceutics
Structural Heart Disease
TAVR
Tricuspid Valve
Vascular & Endovascular
Management
Back
|
Management
Chest Pain Guidelines
Compensation
Economics
Education & Training
Legal News
Patient Care
Policy & Regulations
Professional Associations
Quality
Revenue
Staffing
Technology
Back
|
Technology
AI
Cardiac Imaging
Cath Lab
CT
CVIS
ECG
Echo
EP Lab
Informatics
MRI
Nuclear Cardiology
Remote Monitoring
Videos
Conferences
Back
|
Conferences
ACC
AHA
ASE
ASNC
ESC
EuroPCR
HFSA
HRS
HRS
SCAI
SCCT
SIIM
SNMMI
STS
TCT
VIVA
Custom Content
Back
|
Custom Content
Experience Stories
Webinars & Videos
Subscribe
Forty Under 40 Award
Back
|
Forty Under 40 Award
Class of 2026
Class of 2025
Search form
Search
August 2023
Looking back at ESC Congress 2023 | Pre-TAVR CT scans | Weight loss products recalled due to heart risks
(
08/31/2023
)
Statin use after bleeding strokes | Treating TAVR patients with low-flow, low-gradient AS & severe MR
(
08/30/2023
)
Cardiac Imaging Highlights: AI-enabled echo | Deferred testing for chest pain | Diagnosing HCM
(
08/30/2023
)
First drugs chosen for Medicare price negotiations | The long-term outcomes of valve-in-valve TMVR
(
08/29/2023
)
New data on intravascular imaging-guided PCI & pulsed-field ablation | FDA clears AFib-detecting scale
(
08/28/2023
)
Heart Rhythm Highlights: AI models gain FDA approval | ESC Congress 2023 | Fluoroscopy-free ablation
(
08/28/2023
)
Semaglutide & heart failure | Deferred testing for low-risk chest pain patients | The first CVD drug of its kind
(
08/25/2023
)
Abiomed's Class I recall | TAVR in patients with a very low gradient | ESC Congress 2023 | More from the last week
(
08/25/2023
)
Economics Highlights: Shockwave Medical makes a move | Starting salaries in cardiology | SCAI calls out ABIM
(
08/25/2023
)
AI-enabled echo system makes its debut | Bad news for Medtronic | Key sessions at ESC Congress 2023
(
08/24/2023
)
ASE 2023: Advances in Interventional echo | Lobbyists on key Medicare policies
(
08/24/2023
)
FDA panel's ruling on ultrasound system for renal denervation | Beloved cardiologist remembered by colleagues
(
08/23/2023
)
Care Delivery: New guidelines on chronic coronary disease | AI spots heart defects missed by the human eye
(
08/23/2023
)
TAVR in patients with a very low gradient | Interventional echo expected to grow | Missed opportunities for CVD patients
(
08/22/2023
)
How to handle bullying & discrimination in cardiology | Chest pain 1 year after a heart attack
(
08/21/2023
)
Heart Health Highlights: New data on the weight loss drug semaglutide | Exercise & HCM management
(
08/21/2023
)
A new recall for Abiomed | Previewing ESC Congress 2023 | Implantation depth & LAAO outcomes
(
08/18/2023
)
Shockwave Medical makes a move | 5 recalls in 8 months for heart devices | AI & echo | More from the last week
(
08/18/2023
)
News Alert: Abiomed recalls heart pump catheter labeling after 12 injuries
(
08/18/2023
)
5 recalls in 8 months for troubled heart devices | Interventional echocardiographers play a key role | AI spots heart defects
(
08/17/2023
)
News Alert: FDA announces yet another recall for troubled heart devices
(
08/17/2023
)
Vascular & Endovascular: The best alternatives to transfemoral TAVR | Cardiology groups voice concerns
(
08/17/2023
)
An expert's take on AI & echocardiography | New TAVR valve saves cardiologists time | FDA clears 2 algorithms
(
08/16/2023
)
First AI model of its kind gains FDA approval | Weight loss drug's potential impact on patient care
(
08/15/2023
)
Starting salaries in cardiology down 10% | Shockwave Medical announces $650M private offering
(
08/14/2023
)
‘Unfair & unjustified’ certification policies | Alternative TAVR techniques | Microplastics in heart tissue?
(
08/11/2023
)
Heart devices recalled again | Colchicine before PCI | Expert interviews on HCM | More from the last week
(
08/11/2023
)
Structural Heart Disease: TriClip triumphs | Abbott recalls delivery sheath | Surgeon sues hospital after TAVR controversy
(
08/11/2023
)
Troubled heart devices recalled again | Surgery & interventional therapies for HCM | FDA's new labeling guidance
(
08/10/2023
)
News Alert: FDA announces fourth recall of 2023 for troubled heart devices
(
08/10/2023
)
Focus on hypertrophic cardiomyopathy: ASE HCM Forum coverage
(
08/09/2023
)
Imaging's role in the treatment of HCM | FDA approves new cryoablation system for AFib | Fasting before TAVR
(
08/09/2023
)
DRAFT 1 - Focus on hypertrophic cardiomyopathy: ASE HCM Forum coverage
(
08/09/2023
)
Weight loss drug reduces CV risks | HCM may be widely underdiagnosed | TAVR controversy leads to lawsuit
(
08/08/2023
)
News Alert: Weight loss drug semaglutide reduces risk of adverse cardiovascular events
(
08/08/2023
)
TAVR Highlights: A key recall after 26 injuries | New valve makes its debut | Permanent pacemakers | Much more
(
08/08/2023
)
Colchicine before PCI | NFL player's AFib diagnosis | Cardiologist remembered as a ‘true legend’
(
08/07/2023
)
Heart Failure Highlights: Key recalls | Consistency in HCM care | Keto diet shows potential | Much more
(
08/07/2023
)
FDA approves several devices for fluoroscopy-free ablation | More consistency still needed when treating HCM
(
08/04/2023
)
Abbott pulls Trifecta heart valves | The top 25 U.S. hospitals for cardiology | SCCT 2023 | More from the last week
(
08/04/2023
)
WHO endorses polypills for CVD | Expanding Medicaid linked to better care for heart patients
(
08/03/2023
)
July's Top 10 Stories: Implantable heart devices recalled | Salaries in cardiology | AI in the echo lab | Much more
(
08/03/2023
)
Top U.S. cardiac hospitals | Do infections cause MI? | Patient advocates help advance HCM care
(
08/02/2023
)
Key trends in cardiac CT at SCCT 2023 | first patient implanted with new Chinese TAVR valve
(
08/01/2023
)
Design by Adaptive Theme
Trimed Popup